Original Research

Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses

Fernet M, Beckerman B, Abreu P, Lins K, Vincent J, Burgess E

Vascular Health and Risk Management 2018, 14:233-246

Published Date: 20 September 2018